-
U251; MCF-7
MAPK/ERK (other)
RT-qPCR; Transfection; MTT; Transwell Assay; Annexin V/PI Flow Cytometry; Cell Cycle Assay; Western Blot; Bioinformatics Analysis
In U251 glioma and MCF-7 breast cancer cells, the nitrogenous heterocyclic compound downregulated circUBAP2, which the authors describe as an oncogenic circRNA and associate with MAPK/ERK signaling in their pathway table.
0.4635
Computer-aided drug design and inhibitive effect of a novel nitrogenous heterocyclic compound and its mechanism on glioma U251 cells and breast cancer MCF-7 cells.
biological research